Male Factor Fertility: The Overlooked Variable in Embryo Outcomes
If you have been told his semen analysis is normal and the focus has shifted back to you, that is not the full picture.
We hear this from almost every couple who comes to Fab Fertile for a Functional Fertility Second Opinion. She has changed her diet, started the supplements, booked every appointment. He got a semen analysis, it came back normal, and that was considered sufficient. So the investigation stayed on her side her hormones, her reserve, her egg quality, her protocol while half of the biological picture went unexamined.
A normal semen analysis is not a complete evaluation. It measures count, motility, and morphology. It does not measure sperm DNA integrity, oxidative stress, the hormonal environment, or the metabolic and inflammatory picture the sperm are developing inside. Those are exactly the factors that determine whether fertilization leads to a viable embryo.
Male factor contributes to fertility challenges in approximately 40 to 50 percent of cases. Not occasionally. Not as a secondary consideration. Half the time. And in most of the couples we work with, by the time they reach us the male side has received a fraction of the investigation the female side has.
This article is for both of you. Because when we evaluate both partners with the same depth the same functional lens, the same commitment to finding what has been missed the picture almost always looks different than it did when only one side was being examined.
Download the Embryo Audit Checklist to start reviewing what may have been missed on both sides.
Download the Embryo Audit Checklist
What does a standard semen analysis actually measure?
A standard semen analysis evaluates sperm count, motility, and morphology. The World Health Organization (WHO) 2021 sixth edition sets lower reference limits based on the fifth percentile of fertile men: semen volume 1.5ml, sperm concentration 15 million per millilitre, total sperm number 39 million per ejaculate, total motility 40 percent, progressive motility 32 percent, morphology 4 percent, vitality 58 percent. Importantly, the WHO itself states that these fifth percentile values alone are not sufficient to evaluate male fertility and that a result within range does not confirm fertility. There is substantial overlap between fertile and subfertile men on these parameters. At Fab Fertile we use functional reference ranges that target optimal rather than minimum thresholds, and we look beyond count, motility, and morphology to evaluate sperm DNA integrity, oxidative stress, hormonal environment, and inflammatory load none of which are captured in a standard semen analysis.
Source: World Health Organization. Laboratory Manual for the Examination and Processing of Human Semen, Sixth Edition. Geneva: WHO; 2021.
Can male factor affect IVF outcomes even when the semen analysis is normal?
Yes. A standard semen analysis measures count, motility, and morphology not sperm DNA integrity or oxidative stress. Sperm DNA fragmentation is independently associated with lower blastocyst development rates, higher embryo arrest, increased miscarriage risk, and failed IVF cycles even when all standard semen parameters fall within normal range. The WHO itself notes that standard reference limits do not reliably separate fertile from subfertile men. The functional evaluation at Fab Fertile looks at both partners together sperm DNA integrity, hormonal picture, gut health, metabolic status, seminal microbiome, and environmental load because embryo development is a shared biological process, not a solo performance.
Why Embryo Development Is Shared Biology
Most of the conversation about embryo quality focuses on the egg. Egg quality matters mitochondrial energy, chromosomal integrity, the biological environment of the 90-day maturation window. All of that is real and all of it is addressed in our article on
Most of the conversation about embryo quality focuses on the egg. Egg quality matters mitochondrial energy, chromosomal integrity, the biological environment of the 90-day maturation window. All of that is real and all of it is addressed in our article on Egg Quality and Ovarian Signaling.
But embryo development does not stay on the female side of the biology for long.
In the first 48 to 72 hours after fertilization, early cell division is driven primarily by the egg. The maternal cytoplasm and mitochondrial energy supply carry the embryo through the first cleavage stages. Around Day 3, the embryo begins activating the paternal genome to direct further development. From this point the genetic integrity of both partners becomes increasingly relevant to whether the embryo continues to grow.
This is the biological basis for why we always evaluate both partners when embryos are arresting or cycles are failing. When embryos look strong on Day 3 and then stall before Day 5, the default explanation is egg quality. Sometimes that is accurate. Often it is part of the picture. But the evidence tells us that elevated sperm DNA fragmentation is associated with impaired embryo development, higher embryo arrest rates, and increased miscarriage risk and that association holds even when standard semen parameters are normal.
That does not mean sperm DNA fragmentation is always the cause of Day 3 to Day 5 drop-off. Embryo development is complex and multiple variables interact egg quality, mitochondrial function, laboratory conditions, chromosomal status. What it means is that the male side cannot be cleared based on count, motility, and morphology alone when embryos are not developing as expected. The evidence for sperm DNA fragmentation as a contributing factor is strong enough that not testing it leaves a meaningful gap in the picture.
The same logic applies to the seminal microbiome. Seminal fluid carries its own microbial environment, and when that environment contains inflammatory organisms or dysbiotic patterns, it directly affects the vaginal and uterine environment at the time of conception or transfer. We see this in cases of repeated implantation failure where the female microbiome has been addressed and keeps returning to dysbiosis. The source is often the seminal microbiome, which was never evaluated. Partners pass organisms back and forth without either showing obvious symptoms. Addressing one partner without the other leaves the shared environment unchanged.
Fertility is not a female organ event with a male delivery mechanism. It is a shared biological process at every stage from the genetic material both partners contribute, to the microbial environment they share, to the inflammatory load that shapes whether a pregnancy holds.
For more on how the shared microbiome affects implantation outcomes, see our article on the shared environment and unexplained IVF failure. For the Day 3 to Day 5 transition and what the pattern can indicate, our article on the Day 3 cliff covers this in depth.
[DEV: ILLUSTRATION PLACEHOLDER: Shared biology diagram female contribution (egg, mitochondria, uterine environment) alongside male contribution (sperm DNA integrity, seminal microbiome, oxidative load) converging at fertilization and early embryo development. Caption: Embryo outcomes reflect the biology of both partners. Evaluating only one side leaves the picture incomplete.]
The Conventional Evaluation and What It Misses
The standard fertility evaluation for a male partner follows a predictable path. A semen analysis is ordered. Results are compared against WHO minimum reference thresholds. If count, motility, and morphology clear those thresholds, the result is labeled normal and the investigation ends.
That is the problem.
The WHO 2021 sixth edition reference values represent the fifth percentile of fertile men the statistical floor below which a result is flagged as potentially problematic. The WHO itself states clearly that these values alone are not sufficient to evaluate male fertility and that there is substantial overlap between fertile and subfertile men on these parameters. A result that clears the minimum threshold does not confirm fertility. It confirms that the result is not in the bottom five percent of fertile men. Those are not the same thing.
And that is before we get to what the semen analysis does not measure at all.
Sperm DNA fragmentation breaks or damage within the genetic material of the sperm is not part of a standard semen analysis. It is not ordered unless there is a clear male diagnosis or the clinician specifically requests it. Yet the evidence linking DNA fragmentation to recurrent pregnancy loss, failed IVF cycles, and poor embryo development is well established. A man can have normal count, normal motility, normal morphology, and significant DNA fragmentation. The standard analysis will not find it.
Oxidative stress is another gap. Sperm are uniquely vulnerable to oxidative damage because they have very little cytoplasm and therefore limited antioxidant defense. Elevated oxidative stress driven by poor metabolic health, chronic inflammation, gut infections, environmental toxin exposure, or lifestyle factors damages the sperm membrane and DNA without altering the parameters a standard analysis measures.
The hormonal picture is almost never fully evaluated. Testosterone is rarely tested unless there is an obvious symptom. Thyroid function is not part of a standard male fertility workup despite its role in sperm production and motility. Cortisol and adrenal function are not evaluated at all.
The gut microbiome and seminal microbiome are not assessed. The inflammatory markers hsCRP, homocysteine are not ordered. The environmental toxin load is not investigated. And the impact of age on sperm quality is almost never discussed, despite clear evidence that sperm DNA fragmentation rates increase over time.
The population-level context for all of this is significant. A 2017 meta-analysis co-authored by Dr. Shanna Swan, examining data from 185 studies and nearly 45,000 men, found that sperm concentration among men from North America, Europe, and Australia declined by more than 50 percent between 1973 and 2011. A 2022 follow-up analysis found the overall decline reached 51.6 percent between 1973 and 2018 and that the rate of decline accelerated after 2000. Swan described this as a canary in the coal mine, with environmental and lifestyle factors pesticide exposure, endocrine-disrupting chemicals, stress, obesity as the likely drivers. The man who comes in for a semen analysis today is being compared against minimum thresholds set from data on a population whose sperm quality was already declining.
At Fab Fertile we use functional reference ranges that target optimal rather than minimum. For count we look for 60 to 70 million per millilitre. For motility we target above 50 percent progressive. For morphology we look for above 8 percent normal forms. These are the targets we use in our case reviews not because they are universal clinical standards, but because they reflect what we consistently see associated with better outcomes in the couples we work with.
For more on the environmental drivers of declining sperm quality, listen to our episode with Dr. Shanna Swan on how to improve declining sperm counts and egg quality and our episode on how to address men's reproductive health.
One Couple's Experience: Annie and Miles
Annie and Miles came to Fab Fertile with a picture that is common in the couples we work with. She had low AMH. He had already had a varicocele repair. His semen analysis showed motility at 17 to 18 percent well below what we look for functionally. They were trying to figure out what to do next.
What they had not yet done was address both sides of the picture together, systematically, with testing to guide the work.
Miles had the varicocele surgery before they joined the program, which addressed one structural contributor. But the post-surgical numbers still reflected a system that had not fully recovered. Motility at 17 to 18 percent is not a number to work around. It is a number to investigate and address directly because it tells you the environment those sperm are developing in has not changed enough yet.
Through the program, Miles focused on diet, stopped drinking, and followed the targeted recommendations from his testing. Six months in, his motility had risen to above 30 percent. His sperm concentration tripled.
Those are not small shifts. That is what the 74-day sperm lifecycle means in practice. The sperm being produced today reflect the health inputs of the last two to three months. Change those inputs in a meaningful, targeted way and the numbers change with them.
Annie conceived naturally. Both sides of the picture were addressed. That is not a coincidence it is the entire point of evaluating the couple together.
Watch Annie and Miles share their story: Natural Pregnancy After Low AMH and Male Factor Fertility
Five Patterns We Consistently See in Male Factor Fertility
These are not the only factors that influence sperm health. But they are the ones that come up most consistently in our case reviews and the ones most reliably missed when the evaluation stops at a standard semen analysis. Each pattern has its own biological mechanism and in most of the couples we work with, more than one is operating at the same time.
Pattern 1: Sperm DNA Fragmentation and Oxidative Load
A normal semen analysis does not rule out DNA damage. This is the single most important thing to understand about male factor fertility, and it is still not standard practice to test for it.
Sperm DNA fragmentation refers to breaks or damage within the genetic material of the sperm. Sperm can have adequate count, normal motility, and acceptable morphology while still carrying significant DNA damage that affects fertilization, embryo development, and pregnancy outcomes. The standard semen analysis does not measure it. It is not ordered unless there is an existing male diagnosis or the clinician specifically requests it. In most of the couples we review, it has never been tested.
The evidence base is substantial. A systematic review and meta-analysis found that live birth rates after IVF were 27 percent higher in couples with low sperm DNA fragmentation compared to high fragmentation groups, and 11 percent higher after ICSI. The 870 ICSI cycles study confirmed that each 1 percent increase in DNA fragmentation reduced the odds of achieving top-quality blastocysts on Day 5 by 2.5 percent. A separate analysis found that high fragmentation was associated with significantly lower fertilization rates, lower cleavage rates, and higher miscarriage rates after embryo transfer.
An important nuance: the impact of DNA fragmentation appears strongest on embryo development and natural or IVF conception outcomes, and less dominant when euploid embryos confirmed by preimplantation genetic testing are transferred. This does not make it irrelevant it means the context matters and that fragmentation should be interpreted alongside the full clinical picture, not as a standalone number.
The primary driver of DNA fragmentation is oxidative stress. Sperm have very little cytoplasm and therefore limited antioxidant defense. They are uniquely vulnerable to oxidative damage from poor metabolic health, chronic inflammation, gut infections, environmental toxin exposure, elevated temperature, and lifestyle factors including alcohol and smoking. This is why addressing fragmentation is not about a single supplement it is about identifying and reducing the oxidative load across the full 74-day sperm maturation window.
For more on how DNA fragmentation affects embryo outcomes specifically, see our article on the Day 3 cliff and our episode on how to improve low sperm count, motility, and DNA fragmentation.
Pattern 2: Hormonal Disruption Testosterone, Thyroid, and Cortisol
Hormonal evaluation for the male partner in a fertility workup is almost never comprehensive. Testosterone may be checked if there are obvious symptoms. Thyroid function is rarely ordered. Cortisol and adrenal status are not considered part of the picture at all.
Testosterone is essential for sperm production. Low testosterone does not only affect libido and energy it directly impairs spermatogenesis. The pattern we see in younger men is increasingly common: testosterone levels that fall within the low-normal range on a standard panel, causing no obvious clinical flags, but reflecting a hormonal environment that is not supporting optimal sperm production.
A critical point on testosterone replacement therapy: exogenous testosterone signals the brain to stop producing the hormones that drive sperm production. Luteinizing hormone and follicle-stimulating hormone both decline. Spermatogenesis can be severely suppressed or halted entirely. Men who have been on testosterone replacement therapy and are now trying to conceive need to raise this history with their urologist and understand the timeline for recovery.
Thyroid function is directly relevant to sperm quality. Thyroid hormone influences sperm motility, morphology, and DNA integrity. Subclinical hypothyroidism and thyroid autoimmunity patterns that fall within standard reference ranges can impair these parameters without triggering a formal diagnosis. We evaluate a full thyroid panel including Free T3, Free T4, Reverse T3, and thyroid peroxidase antibodies for the male partner, not just TSH.
Cortisol and stress load are consistently underestimated on the male side. Chronic stress elevates cortisol, suppresses testosterone production, and creates the hormonal environment for reduced sperm quality. The Dried Urine Test for Comprehensive Hormones (DUTCH) gives us the cortisol rhythm picture not a single blood draw and regularly reveals patterns in male partners that are directly influencing their sperm health picture and have never been evaluated.
For more on the hormonal picture in male fertility, listen to our episode with Dr. Deb Matthew on how to address missed healing opportunities for male factor infertility and our episode on how stress and other factors negatively impact sperm quality.
Pattern 3: Gut Health, Seminal Microbiome, and Reinoculation
The gut microbiome influences male fertility through multiple pathways hormone metabolism, nutrient absorption, inflammatory signaling, and immune regulation. When the gut is dysbiotic, the downstream effects on sperm quality are real and measurable.
We consistently see themes in male partners that point directly to gut health as an underlying driver: low stomach acid impairing nutrient absorption, mineral deficiencies that do not respond to supplementation, blood sugar dysregulation, and chronic low-grade inflammation that shows up in inflammatory markers but has never been traced to a source.
The seminal microbiome adds another layer. Seminal fluid carries its own microbial environment, and when that environment contains inflammatory organisms Ureaplasma, Mycoplasma, or anaerobic bacteria it directly affects sperm quality and the vaginal and uterine environment of the female partner at conception or transfer. This is the reinoculation pattern. Partners pass organisms back and forth without either showing symptoms. The female microbiome is addressed and returns to dysbiosis. The male side was never evaluated.
Addressing one partner without the other in this scenario does not resolve the shared biological environment. It delays resolution and adds cycle after cycle of unexplained outcomes.
For more on the seminal microbiome and shared microbial patterns between partners, listen to our episode on embryo transfer prep and the hidden factors that could make or break success and our article on the shared environment and why unexplained IVF failure is often untested.
Pattern 4: Metabolic Health Blood Sugar, Lipids, and Nutrient Deficiency
Metabolic health is one of the most consistently underinvestigated areas in male fertility evaluation. Blood sugar dysregulation, insulin resistance, suboptimal lipid profiles, and nutrient deficiencies all have direct, documented effects on sperm quality and none of them are part of a standard semen analysis or a standard fertility consultation.
Blood sugar dysregulation impairs sperm motility and increases oxidative stress. Elevated insulin suppresses testosterone and disrupts the hormonal signaling pathway for sperm production. We see blood sugar patterns in male partners that have never been flagged not because they are diabetic, but because their fasting glucose or insulin falls within the conventional normal range while the functional picture tells a different story.
Cholesterol is often overlooked in this context. Testosterone is synthesized from cholesterol. When cholesterol is too low in men who have aggressively cut dietary fats or been placed on statins testosterone production can be compromised. When it is too high, the liver and inflammatory burden it reflects creates a downstream effect on sperm quality.
Nutrient deficiencies are extremely common in the male partners we work with and extremely rarely tested. Zinc is directly involved in sperm production, motility, and DNA integrity. Magnesium is required for testosterone synthesis. Vitamin D deficiency is associated with poorer sperm parameters. B12 and folate are required for DNA methylation, which affects sperm DNA integrity. CoQ10 supports mitochondrial energy production in sperm. None of these are tested in a standard fertility workup unless the clinician specifically orders them.
For more on the metabolic and nutrient picture in male fertility, listen to our episode on why focusing on the whole body helps to improve sperm quality and our episode on how to address men's reproductive health.
Pattern 5: Environmental and EMF Exposure
The population-level decline in sperm quality documented by Dr. Shanna Swan and colleagues is not happening in a vacuum. The 51.6 percent decline in sperm concentration between 1973 and 2018, with the rate of decline accelerating after 2000, points to environmental inputs as a primary driver. Endocrine-disrupting chemicals BPA, phthalates, pesticide residues, PFAS compounds interfere with testosterone production, sperm development, and DNA integrity.
The most impactful changes are often straightforward: removing plastics from food storage and water bottles, switching to non-toxic personal care products, choosing organic where possible, and reducing phone and laptop proximity to the reproductive organs. These are not fringe recommendations. They are supported by a growing evidence base and consistently missing from male fertility consultations.
EMF exposure is rarely discussed in conventional fertility contexts and consistently comes up in our content. Research has documented associations between mobile phone radiation and reduced sperm count, motility, and morphology, with proposed mechanisms including oxidative stress and thermal effects on the testes. The phone in the front pocket is a specific, modifiable exposure that many men have never been asked about.
Occupational exposures are another gap. Firefighters, pilots, agricultural workers, those working with industrial chemicals or solvents these exposures have documented associations with impaired sperm quality and are almost never raised in a standard fertility consultation.
For more on environmental toxins and sperm health, listen to our episode with Dr. Shanna Swan on how to improve declining sperm counts and egg quality and our episode on how to protect your fertility from EMF exposure.
Not Sure Where to Start?
If his semen analysis came back normal and the investigation stopped there, part of the picture has not been evaluated.
A normal result on count, motility, and morphology does not assess DNA integrity, oxidative stress, hormonal environment, gut health, seminal microbiome, or environmental load. Those are exactly the factors that determine whether fertilization leads to a viable embryo and whether a pregnancy holds.
Most of the male partners we work with have already made some changes. They have taken supplements, adjusted their diet, reduced alcohol. But without testing to guide the work, those changes are generalized rather than targeted. Knowing what is actually driving the pattern changes the approach completely.
A Functional Fertility Second Opinion reviews both partners together. Not the female side with a brief male addendum. Both sides, with the same depth, the same functional lens, and a clear picture of what has been missed and what is worth addressing before the next cycle.
Male Factor Fertility: The Overlooked Variable in Embryo Outcomes
This positions you as different from female-only fertility coaching.
Why Most Plans Miss the Mark
You were told his semen analysis is normal so the male side has been ruled out.
But a standard semen analysis measures count, motility, and morphology. It does not assess DNA integrity, oxidative stress, hormonal environment, gut health, or environmental load. A result within the WHO minimum reference range does not confirm optimal sperm function. It confirms the result is not in the bottom fifth percentile of fertile men. Those are not the same thing, and the WHO itself states that these values alone are not sufficient to evaluate male fertility.
You were told he already had a varicocele repair or other intervention so the male factor is addressed.
But structural interventions address one contributor. They do not change the metabolic environment, the oxidative load, the gut health, the nutrient status, or the hormonal picture the sperm are developing inside. Miles had his varicocele repair before joining the Fab Fertile program. His motility was still at 17 to 18 percent. It took addressing the full biological picture diet, lifestyle, targeted changes based on testing for his concentration to triple and his motility to rise above 30 percent.
You were told his testosterone is normal.
But testosterone within the standard reference range is not the same as testosterone at a level that supports optimal spermatogenesis. Standard testosterone panels use population-based reference ranges that include men with poor metabolic health, chronic stress, and significant lifestyle burden. And if he has ever used testosterone replacement therapy or anabolic steroids, that history needs to be raised directly with a urologist exogenous testosterone suppresses the hormonal signals required for sperm production and the effects can persist well after cessation.
You were told the focus should be on egg quality because embryos are arresting or not developing.
But embryo development is shared biology. From Day 3 onward the paternal genome plays an increasingly active role in directing embryo growth. When embryos consistently look strong on Day 3 and stall before Day 5, DNA fragmentation is one of several patterns worth investigating. A pattern we see regularly: repeated cycles attributed entirely to egg quality, with DNA fragmentation never tested on the male side.
You were told he already takes supplements so his nutrition is covered.
But supplementing without testing means taking things that may not address what is actually driving the pattern. Zinc, magnesium, vitamin D, B12, folate, CoQ10 all relevant to sperm health, all commonly deficient, all requiring a baseline to know whether supplementation is correcting a deficiency or adding to an already adequate level. What we find consistently: some interventions are working against the pattern rather than with it because no one measured the baseline.
You were told lifestyle changes should be enough.
But generalized lifestyle recommendations are not the same as a personalized protocol built on what the testing actually shows. Dr. Shanna Swan's research documented a more than 50 percent decline in sperm concentration among Western men between 1973 and 2018, with the rate of decline accelerating after 2000. The environmental and metabolic inputs driving that decline do not respond to general advice. They respond to targeted investigation and specific changes based on what the individual's picture actually shows.
For more on what a complete functional evaluation of the male partner looks like, listen to our episode on why including your partner sets you up for pregnancy success and our episode on normal semen analysis, failed IVF -- what most couples are never told.
A Functional Fertility Audit: Male Factor
Understanding the Numbers: WHO Minimum Reference Limits vs. Fab Fertile Functional Targets
The WHO 2021 sixth edition sets lower reference limits based on the fifth percentile of fertile men the statistical floor below which a result is flagged. The WHO itself states these values alone are not sufficient to evaluate male fertility and that there is substantial overlap between fertile and subfertile men on these parameters. At Fab Fertile we use functional targets that reflect what we look for in relation to optimal outcomes in the couples we work with not population minimums.
|
Parameter |
WHO 2021 Lower Reference Limit (5th Percentile) |
Fab Fertile Functional Target |
|---|---|---|
|
Volume |
1.5 ml |
2.0 ml or above |
|
Total Sperm Count |
39 million per ejaculate |
80 million per ejaculate or above |
|
Concentration |
15 million per ml |
60 to 70 million per ml |
|
Total Motility |
40 percent |
50 percent or above |
|
Progressive Motility |
32 percent |
40 percent or above |
|
Morphology |
4 percent normal forms |
8 percent normal forms or above |
|
Vitality |
58 percent live |
70 percent or above |
|
DNA Fragmentation Index |
Not part of standard semen analysis. No universally agreed threshold published meta-analysis cites 20 percent as a reference point for distinguishing fertile from infertile men, but this varies by assay type (SCSA, TUNEL, SCD, Comet). AUA/ASRM 2024 recommends testing for RPL. EAU 2024 recommends for RPL and unexplained infertility. NICE (UK) does not include it in guidelines. NHS rarely offers it. |
Evaluated when there is recurrent pregnancy loss, unexplained infertility, embryo arrest, or failed IVF regardless of standard semen parameters. Result interpreted in context of assay used, clinical history, and full couple picture. |
Source for WHO values: World Health Organization. Laboratory Manual for the Examination and Processing of Human Semen, Sixth Edition. Geneva: WHO; 2021.
Note on Fab Fertile targets: These reflect the functional reference ranges used in our case reviews. They are not universal clinical standards. A result between the WHO minimum and the Fab Fertile functional target is not automatically a problem it is a data point to interpret alongside the full picture.
Note on DNA fragmentation: Thresholds vary by assay. Results should be reviewed by a urologist or reproductive specialist alongside the full clinical picture. A result below the assay-specific threshold does not exclude sperm DNA as a contributing factor when other clinical indicators are present.
This is how we read the full male fertility picture at Fab Fertile, compared to what a standard workup typically covers. The italicized notes describe what the pattern often looks like clinically.
|
Area |
Conventional View |
Fab Fertile Pattern Interpretation |
|---|---|---|
|
Semen Analysis and Evaluation Scope |
Standard semen analysis evaluates count, motility, and morphology against WHO minimum reference thresholds. A result within range is labeled normal and investigation ends. Single analysis often used despite known variability between samples. |
Semen analysis reviewed against functional reference ranges targeting optimal rather than minimum. Interpreted alongside full blood chemistry, hormonal picture, and inflammatory markers not as a standalone result. The pattern we see most often: one semen analysis, result within WHO minimum range, labeled normal, investigation closed. The functional picture oxidative stress, DNA integrity, hormonal environment was never opened. |
|
Sperm DNA Fragmentation and Oxidative Stress |
DNA fragmentation testing not routinely ordered unless semen analysis is abnormal or there is a clear male diagnosis. Oxidative stress not assessed. Standard analysis does not measure either parameter. |
Sperm DNA fragmentation evaluated when there is recurrent pregnancy loss, unexplained infertility, embryo arrest, or failed IVF cycles regardless of semen analysis result. Oxidative stress markers evaluated alongside metabolic health, inflammatory burden, and lifestyle inputs. A normal semen analysis does not rule out DNA damage. The pattern: embryos arrested at Day 3 to Day 5, semen analysis normal, DNA fragmentation never evaluated. When we look at it, fragmentation is elevated. The drivers are almost always oxidative gut infections, blood sugar dysregulation, environmental load, alcohol. All of it addressable in the 74-day window. |
|
Hormonal Picture Testosterone, Thyroid, Cortisol |
Testosterone tested if symptoms are present. Thyroid not routinely evaluated in male fertility workup. Cortisol and adrenal function not assessed. TRT history not always connected to current fertility picture. |
Full hormonal evaluation including testosterone, LH, FSH, full thyroid panel with Free T3, Free T4, Reverse T3, and thyroid peroxidase antibodies, and cortisol rhythm via the Dried Urine Test for Comprehensive Hormones (DUTCH). TRT and steroid history reviewed explicitly. A urologist should be consulted on timeline for recovery following TRT cessation. The pattern: testosterone in the low-normal range, never flagged, never connected to sperm quality. Thyroid antibodies present, never tested. Cortisol flat across the day from chronic stress, never evaluated. Each one individually below the threshold for action. Collectively, a hormonal environment that is not supporting optimal sperm production. |
|
Gut Health and Seminal Microbiome |
Gut health not considered part of male fertility evaluation. Seminal microbiome not assessed. Infections evaluated only if semen analysis shows leukocytes above threshold or if there are obvious symptoms. |
Comprehensive stool testing to identify gut dysbiosis, infections, and inflammatory markers. Seminal microbiome evaluation where reinoculation patterns are suspected particularly in cases of repeated female microbiome dysbiosis despite intervention. Food sensitivity testing and elimination diet for both partners. The clue in the history: female microbiome addressed, returns to dysbiosis, male side never evaluated. Or male partner with persistent digestive issues, poor nutrient absorption, mineral deficiencies that do not respond to supplementation. The gut is driving the inflammatory load. The seminal microbiome is passing the pattern back. |
|
Metabolic Health and Nutrient Status |
Metabolic workup not part of standard male fertility evaluation. Nutrient testing not ordered unless there is a specific deficiency diagnosis. General supplement recommended without baseline testing. |
Blood sugar, insulin, fasting glucose, and inflammatory markers evaluated. Full nutrient panel including zinc, magnesium, vitamin D, B12, folate, and CoQ10. Lipid profile reviewed in the context of testosterone synthesis and inflammatory burden. Supplements based on what testing shows, not general population recommendations. What we find consistently: supplements started without a baseline. Some are working against the pattern because levels are already adequate or the absorption issue driving the deficiency has not been addressed. Testing changes the approach completely. |
|
Environmental and EMF Load |
Environmental toxin exposure not assessed unless there is a specific occupational history. EMF exposure not raised in standard fertility consultations. Endocrine disruptor burden not evaluated. |
Environmental toxin load assessed through lifestyle review, occupational history, and targeted testing where indicated. Endocrine-disrupting chemical exposure BPA, phthalates, pesticide residues addressed through specific dietary and lifestyle modifications. EMF exposure and mobile device habits reviewed. The pattern: sperm quality declining without obvious clinical cause. No one has asked about his work environment, his plastic use, his phone habits, his water source. The cumulative chemical burden is suppressing sperm quality in the current 74-day window. These are modifiable inputs. |
The 74-Day Sperm Window
Sperm take approximately 74 days to fully mature from initial cell division in the testes through epididymal maturation to ejaculation. Every sperm in the current cycle reflects the biological environment of the last two and a half months. The diet, the stress load, the sleep, the gut health, the environmental exposures, the alcohol intake, the metabolic picture all of it is encoded in the sperm being produced right now.
This is the functional basis for why the 74-day window matters and why the timing of intervention is not a minor detail.
When couples move immediately into the next IVF cycle or conception attempt without changing the biological environment on the male side, they are working with sperm shaped by the same inputs as the last cycle. The same oxidative load. The same nutrient deficiencies. The same gut dysbiosis. The same hormonal picture. Nothing has changed because nothing has been evaluated.
Miles is the clearest illustration of this in our community. His motility was at 17 to 18 percent when he joined the Fab Fertile program. Six months in working consistently through diet, removing alcohol, following his personalized protocol his motility had risen above 30 percent and his sperm concentration had tripled. That shift did not happen in a week. It happened because the biological environment those sperm were developing inside genuinely changed over multiple 74-day cycles.
This is also why the conversation about male fertility cannot happen two weeks before a retrieval or transfer. Changes made that close to a cycle are not operating in the same maturation window as sperm that will actually be used. The 74-day window is the preparation period. It is where the real work happens.
The parallel with the female 90-day egg maturation window is not coincidental. Both reflect the same biological principle that the quality of the gamete reflects the environment it developed inside, not just the environment it was retrieved from.
What the 74-day window means practically is this. If the male partner starts making targeted changes today addressing gut infections, correcting nutrient deficiencies, reducing oxidative load, stabilizing blood sugar, removing alcohol, reducing environmental toxin exposure the sperm produced two and a half months from now will reflect a different biological environment. That is not a guarantee of a specific outcome. It is a genuine shift in the inputs that determine whether fertilization leads to a viable embryo.
For more on how to use the preparation window effectively before an IVF cycle or natural conception attempt, listen to our episode on how to improve low sperm count, motility, and DNA fragmentation and our episode on why these targeted changes make a difference for male fertility.
From the Fab Fertile Community
These are not outliers. They are what becomes possible when both partners are evaluated and the male side receives the same depth of investigation as the female side.
-
Annie and Miles: Low AMH on her side, poor sperm parameters on his. Both addressed together through the Fab Fertile Method. His sperm concentration tripled and motility rose above 30 percent. Conceived naturally. Watch their story
-
Andrea and Mark: High FSH, low AMH, and low sperm motility. Testing revealed gut infections, thyroid imbalances, nutrient deficiencies, and food sensitivities in both partners. Mark's sperm motility doubled and concentration increased. Pregnant after six months in the program. Read their story
-
Heather and Peter: Three failed IVFs, two miscarriages, DOR diagnosis, and DNA fragmentation confirmed in Peter. Both partners addressed H.pylori alongside full gut, hormone, and nutrient protocols. Successful IVF after one round. Read their story
-
Valerie and Jack: Low AMH, high FSH, two miscarriages, and low sperm volume and concentration in Jack. Full functional evaluation of both partners. Jack's sperm quality improved. Valerie conceived naturally at 43. Listen to their story
What the Research Shows
The research on male fertility is often cited selectively either to reassure couples that a normal semen analysis is sufficient, or to catastrophize about declining sperm counts without connecting that picture to what can actually be done. The more useful lens is to look at what the evidence tells us about the systems behind the pattern.
The global decline in sperm quality.
A 2017 meta-analysis co-authored by Dr. Shanna Swan, examining 185 studies and nearly 45,000 men, found that sperm concentration among men from North America, Europe, and Australia declined by more than 50 percent between 1973 and 2011 with no evidence of leveling off. A 2022 follow-up analysis extended the data to 2018 and found the overall decline reached 51.6 percent with the rate of decline accelerating after 2000. Swan described declining sperm count as a potential canary in the coal mine, with endocrine-disrupting chemicals, pesticide exposure, stress, and obesity as the likely drivers.
Levine H, Swan SH et al. Temporal trends in sperm count. Human Reproduction Update. 2017.
Levine H, Swan SH et al. Temporal trends in sperm count: global analysis. Human Reproduction Update. 2022.
WHO reference limits and their limitations.
The WHO 2021 sixth edition explicitly states that its lower reference limits based on the fifth percentile of fertile men are not sufficient alone to diagnose male infertility, and that substantial overlap exists between fertile and subfertile men on standard semen parameters. A result within range does not confirm fertility. It confirms the result is not in the lowest fifth percentile of fertile men in the reference population.
World Health Organization. Laboratory Manual for the Examination and Processing of Human Semen, Sixth Edition. 2021.
Sperm DNA fragmentation and live birth rates.
A systematic review and meta-analysis found that live birth rates after IVF were 27 percent higher in couples with low sperm DNA fragmentation compared to high fragmentation groups, and 11 percent higher after ICSI. The 870 ICSI cycles study confirmed that each 1 percent increase in DNA fragmentation reduced the odds of achieving top-quality blastocysts on Day 5 by 2.5 percent.
Osman A et al. The effect of sperm DNA fragmentation on live birth rate after IVF or ICSI. Reproductive BioMedicine Online. 2015.
DNA fragmentation and miscarriage.
A systematic review and meta-analysis of thirteen prospective studies found that DNA fragmentation rates were markedly higher in male partners of women with recurrent pregnancy loss than in male partners of fertile controls, with a mean difference of 11.9 percent independent of female factors. Robinson et al. confirmed this association across studies using different assays and RPL definitions.
Robinson L et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Human Reproduction. 2012.
DNA fragmentation thresholds and guidelines.
A meta-analysis cited by both the Agarwal and Esteves clinical practice guidelines found that a 20 percent cut-off value for DNA fragmentation index can distinguish fertile from infertile men but cut-off values are not interchangeable between assay types. The 2024 AUA/ASRM guideline recommends DNA fragmentation testing for recurrent pregnancy loss but not as part of routine initial evaluation. The 2024 EAU guideline recommends it for RPL and unexplained infertility. In the UK, NICE guidelines do not include sperm DNA fragmentation testing and the HFEA has not reviewed the subject since 2018.
Agarwal A et al. Sperm DNA Fragmentation: A New Guideline for Clinicians. World Journal of Men's Health. 2020.
Brannigan RE et al. Male Infertility: AUA/ASRM Guideline. 2024.
Progress Educational Trust. Fertility testing: the forgotten man. 2021.
The gut microbiome and male reproductive health.
A 2024 review in Frontiers in Microbiology confirmed that the gut microbiome is involved in male reproductive function through multiple pathways including testosterone metabolism, inflammatory signaling, and nutrient absorption. Gut dysbiosis has been associated with poorer sperm parameters and elevated oxidative stress in the seminal environment.
Environmental toxins and sperm quality.
Endocrine-disrupting chemicals including BPA, phthalates, pesticide residues, and PFAS compounds have been associated with impaired testosterone production, reduced sperm count, and increased DNA fragmentation in published research. Occupational exposures to heavy metals, solvents, and radiation have documented associations with male infertility across multiple study populations.
Marić T et al. Environmental and occupational exposures associated with male infertility. Arhiv za higijenu rada i toksikologiju. 2021.
Testosterone replacement therapy and fertility.
Published research confirms that exogenous testosterone whether prescribed for low testosterone or used for performance suppresses LH and FSH, significantly impairing spermatogenesis. Recovery after cessation is variable and not guaranteed. Men who have used TRT and are trying to conceive should consult a urologist specifically about this history.
Patel AS et al. Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility. World Journal of Men's Health. 2019.
Rasmussen JJ et al. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels Years after Cessation. PloS One. 2016.
The Case for a Second Opinion
If his semen analysis came back normal and the investigation stopped there, the male side of the picture has not been fully evaluated.
That is not a criticism of the care you have received. A standard semen analysis is what the conventional workup calls for. It measures what it is designed to measure. What it does not do is assess DNA integrity, oxidative stress, hormonal environment, gut health, seminal microbiome, metabolic status, or environmental load. Those are not fringe concerns. They are the factors that determine whether fertilization leads to a viable embryo and whether a pregnancy holds.
In most of the couples we review at Fab Fertile, by the time they reach us the male side has received a fraction of the investigation the female side has. She has had the full workup hormones, ovarian reserve, uterine evaluation, sometimes immune panels. He had a semen analysis, it cleared the minimum threshold, and that was considered sufficient. The investigation stayed on her side while half of the biological picture went unexamined.
A second opinion is not about disputing the semen analysis result. It is about asking whether the full picture has been evaluated before another cycle proceeds with the same biological inputs on both sides.
The couples who come to us for a Functional Fertility Second Opinion are not looking for a miracle. They are looking for information they do not yet have. They want to know whether there is something specific on his side that has been missed, whether it is addressable, and whether the next cycle can start from a genuinely different place for both partners.
In most cases there is. And it is. And it can.
That is what a second opinion is for.
Book a Functional Fertility Second Opinion
Download the Embryo Audit Checklist
For more on how to get both partners evaluated before repeating another cycle, listen to our episode on why including your partner sets you up for pregnancy success and our episode on normal semen analysis, failed IVF.
Related Content
If male factor is part of a broader fertility picture, these articles in the Fab Fertile series address the overlapping systems in depth:
Egg Quality and Ovarian Signaling: Why Age Alone Does Not Explain Outcomes
Low AMH in Context: What the Number Signals and What It Does Not
Diminished Ovarian Reserve: Interpreting Capacity Versus Potential
High FSH and Fertility Decisions: When the Signal Is Misread
Repeated IVF Failure: Patterns That Persist When Protocols Change
Embryo Arrest at Day 3 or Day 5: What the Pattern Often Indicates
Recurrent Pregnancy Loss: What the Pattern Reveals Beyond the Standard Workup
Unexplained Infertility: When the Data Has Not Been Interpreted
Inflammation, Immune Signaling, and Fertility Outcomes: A Pattern-Based View
Nervous System Load and Fertility Outcomes: Why Effort Sometimes Backfires
When Repeating IVF or Moving to Donor Eggs Without New Insight Leads to the Same Outcome
Sources and Research
Robinson L et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Human Reproduction. 2012.
Brannigan RE et al. Male Infertility: AUA/ASRM Guideline. 2024.
European Association of Urology Guidelines on Sexual and Reproductive Health. 2024.
Harris ID et al. Fertility and the aging male. Reviews in Urology. 2011.
Zhang Y et al. Environmental toxin exposure and diminished ovarian reserve markers. Int J Environ Res Public Health. 2022.
Progress Educational Trust. Fertility testing: the forgotten man. 2021.
IFM. The Inflammatory Response and Reproductive Health.
Reviewed by Dr. Labib Ghulmiyyah, MD
This content has been reviewed for alignment with the Fab Fertile clinical framework. The biological patterns and systems-based interpretations discussed in this article reflect the methodology used in Functional Fertility Second Opinion case reviews.
Dr. Labib contributes physician-level perspective to the Fab Fertile clinical framework in an advisory capacity. Clients remain under the care of their own treating physicians for all medical decisions.
Connect with Dr. Labib on LinkedIn
CURRENT VERSION VERIFIED APRIL 2026
The information provided on this website is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
